Accendra Health, Inc.
ACH
$3.23
$0.072.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.11% | 80.98% | -1,076.70% | -2,623.21% | -14.15% |
| Total Depreciation and Amortization | 43.91% | 263.18% | 4.03% | -7.01% | -42.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.40% | -133.93% | 1,529.62% | 13,787.73% | -510.38% |
| Change in Net Operating Assets | -1,579.80% | 346.32% | -789.49% | -1.15% | 96.38% |
| Cash from Operations | -42.81% | -3.96% | -731.78% | -67.62% | 33.79% |
| Capital Expenditure | 9.06% | 40.99% | 5.91% | -52.94% | 0.44% |
| Sale of Property, Plant, and Equipment | 471.04% | 265.84% | 3.56% | 3.61% | -65.92% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.62% | -233.35% | -128.14% | 61.84% | -256.51% |
| Cash from Investing | 211.88% | 644.90% | -45.15% | -50.46% | -2,477.54% |
| Total Debt Issued | -65.37% | -42.06% | 31.21% | 84.56% | 279.02% |
| Total Debt Repaid | 67.98% | 36.38% | 17.30% | -52.25% | -372.11% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.08% | -352.09% | 8,914.95% | 86.47% | 58.49% |
| Cash from Financing | -44.94% | -172.64% | 190.74% | 140.52% | 74.00% |
| Foreign Exchange rate Adjustments | -107.56% | 109.85% | -103.12% | 2,067.19% | 187.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 445.96% | 1,017.31% | 84.41% | 559.85% | 572.02% |